Summary Doxorubicin (DXR) is a potent antitumor drug used worldwide against many forms of human cancer. However, in addition to intercalating into the DNA molecule, this drug generates free radicals that induces chromosome aberrations. Fruits of Salanum melongena are rich in flavonoids. Since several flavonoids have been reported to be efficient antioxidants by scavenging oxygen radicals, the objective of the present study was to investigate the possible protective effect of a standardized extract of Solanum melongena on Wistar rat cells treated with DXR in vivo. The animals were treated by gavage with the extract at 50% of the LD 50 (3 g/kg determined for mice) for 10 consecutive days (group 1) and during 1 day (a single dose, group 2), and submitted to euthanasia 24 h after DXR injection (10 mg/kg body weight) for micronucleus assay (MN) and chromosome preparations. Control groups received a single dose of DXR or S. melongena extract. In both treatments where the animals were treated with the extract and with the DXR simultaneously, rat bone marrow cells developed significantly fewer MN and chromosomal aberrations than those treated with DXR alone.
Antitumor agents like Doxorubicin (DXR) are commonly used to treat many forms of human cancers. However, DXR induces mutations and chromosome aberrations in tumor and non-tumor cells and, cellular enzymes are capable of converting DXR into free-radical metabolites that can give rise to secondary tumors (Bean et al. 1992 , Benchekroun et al. 1992 , Wilson and Gisvold's 1998 . In view of the mechanism of DXR toxicity, it is important to reduce its toxicity to normal cells, a goal that can be achieved by concurrent administration of free-radical-scavenging agents such as antioxidants (Odin 1997, Antunes and .
Several studies have shown that the administration of vitamins, fatty acids and their constituents, chlorophyllin salt and other substances resulted in a protective effect against the chromosomal damage induced by radiation or by chemical agents in the somatic and germ cells of rodents (Khan and Sinha 1996 , Antunes and Takahashi 1998 , Savoldi-Barbosa et al. 1999 , Bez et al. 2001 , Rampazo et al. 2002 .
Eggplant (Solamum melongena) is widely consumed in Brazil and in other countries and its infusion has been used in popular medicine as a hypocholesterolemic agent (Jorge et al. 1998 , Sudheesh et al. 1999 , Guimarães et al. 2000 . Flavonoids extracted from the fruits of Solanum melongena have shown a significant hypolipidemic action in normal and cholesterol fed rats (Sudheesh et al. 1997) and also a potent antioxidant activity (Sudheesh et al. 1999) . Chacon et al. (2002) observed that a standardized S. melongena standardized extract had no genotoxic effects on peripheral blood and bone marrow cells of Wistar rats. The present study was undertaken to investigate the modulatory effect of the simultaneous treatment with S. melongena extract on the clastogenic action of DXR in Wistar rat bone marrow cells.
Materials and methods

Plant material
Eggplant (S. melongena) fruits were obtained in the town of Alfenas. A voucher specimen (No. 00204) has been deposited in the "Laboratório de Fitofármacos" of UNIFENAS, Alfenas, Minas Gerais, Brazil. After drying at room temperature, the fruits were ground (5 kg) and macerated in 85% hydroalcoholic solutions at room temperature for 15 d. The filtered hydroalcoholic extract was evaporated to dryness, yielding 50 g of crude extract. This extract was submitted to the detection and determination of flavonoids by the method of Wagner and Bladt (1996) and as described in the Brazilian Pharmacopeia (2001).
Animals and assay procedures
Experiments were carried out on 6-week-old rats (Rattus norvegicus) weighing approximately 100 g supplied by the UNIFENAS animal house. Food and water were available ad libitum. Rats were divided into experimental groups of 6 animals each (3 males, 3 females). DXR (10 mg/kg body weight) was injected intraperitoneally (0.5 ml/100 g body weight) simultaneously with a single dose of S. melongena extract administered by gavage at a dose of 50% of the LD 50 (determined for mice, 3 g/kg, Carvalho, J. C. T., personal communication). Another group received S. melongena extract for 10 consecutive days at 24 h intervals, and on the ninth day was also injected with DXR. Twenth-four hours after this last treatment the animals were sacrificed. Control groups received a single dose of S. melongena extract or DXR alone. The animals were injected intraperitoneally with 0.5 ml of 0.16% colchicine 90 min before euthanasia, which occurred 24 h after treatment. Both femurs were then excised and bone marrow was flushed into a test tubes using a syringe. For the micronucleus (MN) assay the bone marrow cells were prepared as recommended by Schimid (1976) . The slides were coded, fixed with methanol and stained with Giemsa solution. Two thousand polychromatic erythrocytes (PE) from each animal were scored for MN presence. Bone marrow preparations for analysis of chromosome aberrations in metaphase cells were obtained by the technique of Ford and Hamerton (1956) . One-hundred metaphases per animal were analyzed in order to determine the frequencies of chromosomal aberrations in a blind test. The mitotic index was obtained by counting the number of mitotic cells in 1000 cells analyzed per animal. Slides with typical chromosome aberrations were photographed under an Olympus BX 50 photomicroscope (100ϫ objective). Statistical analysis was carried out by One-way ANOVA (αϭ0.05).
Results and discussion
The results obtained in the in vivo test system are presented in Tables 1 and 2 . As expected, animals treated with DXR had a significantly higher frequency of MN and chromosomal aberrations when compared with Solanum melongena extract alone. In all treatments with DXR the most frequent chromosomal aberrations observed were chromatid breaks, followed by chromatid gaps, deletions and fragments (Fig. 1, Table 2 ). The DXR concentration utilized here was 10 times higher than that recomended for humans. Animals treated with DXR alone, or a combination of S. melongena extract plus DXR had a lower mitotic index compared to S. melongena extract alone although the difference was nonsignificant (Table 2 ). There were no significant differences between sexes. Antunes and Takahashi (1999) observed a significantly lower mitotic index in animals treated with DXR alone or olive oil plus DXR, but these authors used a DXR dose of 90 mg/kg body weight.
Both treatments in which the S. melongena extract was administered simultaneously with DXR resulted in a significant reduction in the mean number of MN (39.28% for a single dose, 47.32% for One hundred cells were analyzed per animal, for a total of 600 cells per treatment. C, Chromatid-type; IC, isochromatid-type; OA, other aberrations: delϭdeletion; fraϭfragments; SEMϭstandard error of the mean. * Significantly different from DXR alone (pϽ0.05). a treatment with 10 doses) and chromosomal aberrations (53.59% for a single dose, 37.51% for a treatment with 10 doses). Animals treated with S. melongena extract for 10 d were better protected against DXR than animals that recept a single dose of the extract although the difference was nonsignificant (Table 2) . Antunes and Takahashi (1999) observed that rat bone marrow cells treated simultaneously with olive oil and DXR developed significantly fewer chromosomal aberrations and abnormal metaphases than those treated with DXR alone. Animals treated with vitamins C and E alone or in combination, plus a single dose of DXR also presented a statistically significant reduction in total number of chromosome aberrations (Antunes and Takahashi 1998) . Olive oil and vitamins C and E are compounds that contribute to the antioxidant defense, like the flavonoids present in S. melongena extract. The role of antioxidants in preventing oxygen radical and hydrogen peroxide induced cytotoxicity and tissue damage in various human disease is becoming increasingly recognized. Manna et al. (1997) demonstrated that substances present in olive oil act as biological antioxidants in Caco-2 ephitelial intestinal cells and protect against oxidative injury. Since Mimnaugh et al. (1979) observed that olive oil did not interfere with the metabolism of DXR in mouse lung, liver or heart in mouse, Antunes and Takahashi (1999) suggested that the possible protection against chromosomal damage is due to the fact that simultaneous treatment with olive oil would allow interception of free radicals generated by clastogenic agents before they reach DNA and induce alterations.
In the present study we observed that the S. melogena extract had the potential to reduced the genotoxic side effects of DXR in the bone marrow cells of Wistar rats. While the use of S. melongena extract combined or not with other compounds as a supplement may provide a good rationale for use in concert with antitumor therapy, it also raises the issue as to whether the pharmacological efficacy of the antitumor agent might itself be compromised by such treatments. The mechanism by which flavonoids from the S. melongena extract protect against the genotoxicity of DXR is still an open question that needs further investigation. 
